Overview

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Status:
RECRUITING
Trial end date:
2028-06-07
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety and efficacy of novel study interventions and combinations in participants with Colorectal Cancer (CRC).
Phase:
PHASE2
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Parexel
Treatments:
Bevacizumab
Fluorouracil
Irinotecan
Leucovorin